Global Diabetes Management Products Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Diabetes Management Products market size will reach US$ million by 2031.
Diabetes Management Products are designed to restore carbohydrate metabolism to a normal state as much as possible through treatment or prevention.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
LPI (LP Information)' newest research report, the “Diabetes Management Products Industry Forecast” looks at past sales and reviews total world Diabetes Management Products sales in 2024, providing a comprehensive analysis by region and market sector of projected Diabetes Management Products sales for 2025 through 2031. With Diabetes Management Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Management Products industry.
This Insight Report provides a comprehensive analysis of the global Diabetes Management Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Diabetes Management Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Management Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Management Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Management Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Management Products market by product type, application, key players and key regions and countries.
Segmentation by Type:
Device
Mobile Apps
Service
Data Management Software
Segmentation by Application:
Hospitals
Medical Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
B. Braun
Dexcom
Roche Diagnostics
Insulet Corporation
Ascensia Diabetes Care
LifeScan
Tidepool
AgaMatrix
Glooko
DarioHealth
Welldoc
Semma Therapeutics
Omada Health
Please note: The report will take approximately 2 business days to prepare and deliver.
Diabetes Management Products are designed to restore carbohydrate metabolism to a normal state as much as possible through treatment or prevention.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
LPI (LP Information)' newest research report, the “Diabetes Management Products Industry Forecast” looks at past sales and reviews total world Diabetes Management Products sales in 2024, providing a comprehensive analysis by region and market sector of projected Diabetes Management Products sales for 2025 through 2031. With Diabetes Management Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetes Management Products industry.
This Insight Report provides a comprehensive analysis of the global Diabetes Management Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Diabetes Management Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetes Management Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetes Management Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetes Management Products.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Management Products market by product type, application, key players and key regions and countries.
Segmentation by Type:
Device
Mobile Apps
Service
Data Management Software
Segmentation by Application:
Hospitals
Medical Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
B. Braun
Dexcom
Roche Diagnostics
Insulet Corporation
Ascensia Diabetes Care
LifeScan
Tidepool
AgaMatrix
Glooko
DarioHealth
Welldoc
Semma Therapeutics
Omada Health
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
111 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Diabetes Management Products Market Size by Player
- 4 Diabetes Management Products by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Diabetes Management Products Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
